Jingfeng Li
Papers
1
Total Citations
10
H-Index
1
About
Dr. Jingfeng Li is a leading surgical oncologist whose research centers on advancing minimally invasive pancreatic surgery, particularly for high-risk patient populations. His most impactful work investigates the feasibility and outcomes of robot-assisted pancreaticoduodenectomy (RPD) in patients with elevated body mass index—a group traditionally considered challenging for minimally invasive approaches. In his landmark 2023 propensity score-matched study, Dr. Li demonstrated that RPD can achieve favorable short-term outcomes compared to open surgery in these patients, challenging conventional surgical wisdom and expanding the indications for robotic techniques. This work has already garnered 10 citations, reflecting its immediate influence on clinical practice. Beyond this, Dr. Li’s broader contributions include refining perioperative protocols and evaluating surgical innovations that reduce complications in complex hepatobiliary and pancreatic procedures. His research bridges the gap between technological advancement and patient-centered care, offering evidence that robotic surgery can be safely extended to higher-risk surgical candidates. For trainees and researchers, Dr. Li’s work exemplifies how rigorous comparative effectiveness research can reshape surgical standards and improve outcomes for some of the most challenging operative scenarios.
Research Focus
Key Achievements
Top Papers
- 1